Table 2.
Geometric mean concentrations of EBOV antibody response according to follow-up visit
| Characteristic | Placebo group N = 291 | Ad26-MVA group N = 281 | rVSV group N = 271 | rVSV-booster group N = 91 |
|---|---|---|---|---|
| D0 | 91 [74; 111] | 100 [75; 134] | 92 [71; 119] | 149 [92; 240] |
| Missing values | 1 | 1 | 0 | 0 |
| D7 | 91 [72; 114] | 93 [73; 120] | 95 [78; 116] | 144 [95; 217] |
| Missing values | 1 | 2 | 1 | 0 |
| D14 | 78 [64; 95] | 207 [166; 257] | 454 [314; 657] | 395 [182; 860] |
| Missing values | 1 | 1 | 0 | 0 |
| D28 | 80 [67; 95] | 264 [210; 331] | 1113 [788; 1573] | 1164 [409; 3316] |
| Missing values | 2 | 0 | 0 | 0 |
| D56 | 127 [107; 151] | 361 [283; 460] | 1012 [796; 1288] | 807 [568; 1147] |
| Missing values | 3 | 1 | 1 | 1 |
| D63 | 111 [91; 135] | 3149 [2042; 4856] | 997 [790; 1259] | 3230 [1711; 6100] |
| Missing values | 2 | 0 | 1 | 1 |
| M3 | 112 [91; 139] | 3227 [2629; 3962] | 1024 [789; 1331] | 2869 [1825; 4511] |
| Missing values | 3 | 1 | 2 | 0 |
| M6 | 107 [90; 128] | 661 [526; 831] | 904 [703; 1162] | 1162 [369; 3655] |
| Missing values | 1 | 1 | 1 | 1 |
| M12 | 92 [77; 110] | 433 [340; 551] | 828 [619; 1108] | 663 [313; 1404] |
| Missing values | 0 | 1 | 0 | 1 |
1Geometric mean [95% CI].